|
Market Cap (18-May) $1,025,901,888 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (5-May) 71,471,994 (10.35%) (8th) |
|
52w High $2.78 |
52w Low $0.93 |
P/E 70.92 |
EPS 0.01 |
PNV released this announcement to the ASX on 26 October 2021, 12:40. The announcement is marked as price sensitive, and is 4 page(s) in length and 479.2kb in size.
You can view all announcements from PNV and see how they appear on a price chart on the announcements page.
At the date of this announcement, PNV was 5.987% short sold according to ASIC data. It was ranked the 14th most shorted stock on the ASX. It is now ranked as the 8th most shorted stock on the ASX with 10.346% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PNV | |
|---|---|
| Appendix 3Y - Robyn Elliott | 30 June 2023, 10:41 |
| Director Share Purchase - David Williams | 8 June 2023, 15:14 |
| Director Share Purchase - David Williams | 8 June 2023, 8:19 |
| Chairman and Managing Director - AGM address | 26 October 2021, 12:40 |
| COVID Trading Themes - Q1 FY22 Update | 20 October 2021, 12:22 |
| Notice of Annual General Meeting | 23 September 2021, 8:24 |
| First patient enrolled in Pivotal Trial - BARDA | 21 September 2021, 13:53 |
You must be logged in to post a reply.
PolyNovo 